NEU 0.15% $13.13 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1314

  1. 310 Posts.
    lightbulb Created with Sketch. 74
    The P3 is not the challenge, the challenge will be getting it to the market promptly, NEU has no infrastructure to do so.
    Running the P3 is one thing, finishing the job is another story...........
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.